Ahmad Nanaa

Genetic features and clinical outcomes of patients with isolated and comutated<i>DDX41</i>-mutated myeloid neoplasms

Hassan B. Alkhateeb, Ahmad Nanaa, David S. Viswanatha et al. · Blood Advances · 2021 · 47 citations · Full text

Life Sciences, Genetics, Hematology +16

Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology

Mazen Osman, Zeynettin Akkus, Dragan Jevremović et al. · Journal of Clinical Medicine · 2021 · 19 citations · Full text

Medicine, Hematology, Pathology +16

Venetoclax plus hypomethylating agents in <scp><i>DDX41</i></scp>‐mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients

Ahmad Nanaa, Rong He, James M. Foran et al. · British Journal of Haematology · 2023 · 18 citations · Full text

Medicine, Hematology, Pharmacology +16

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

Talha Badar, Yenny Alejandra Moreno Vanegas, Ahmad Nanaa et al. · Blood Cancer Journal · 2023 · 17 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms

Mithun Vinod Shah, Abhishek A. Mangaonkar, Kebede H. Begna et al. · Blood Cancer Journal · 2022 · 15 citations · Full text

Life Sciences, Hematology, Oncology +16